Previous Close | 0.0300 |
Open | 0.0100 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 20.00 |
Expire Date | 2024-06-21 |
Day's Range | 0.0100 - 0.0300 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
Over the last year, a good number of insiders have significantly increased their holdings in Liquidia Corporation...
Liquidia stock retook its 50-day line on a U.S. judge's ruling on a patent dispute with United Therapeutics.
On May 31, Judge Andrews denied United Therapeutics’ motion for a preliminary injunction to block the launch of YUTREPIA in the PH-ILD indicationRuling reinforces the clear path for FDA to issue final decision on amended NDA for YUTREPIA to treat both PAH and PH-ILD MORRISVILLE, N.C., June 03, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that on May 31, Judge Andrews of the U.S. District Court for the District of Delaware (District Court) denied the motion for pre